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Human T cell leukemia virus type 1 (HTLV-1) is a 
retrovirus that has been associated with two clinical 
entities, adult T cell leukemia lymphoma (ATL) and 
a neuromyelopathy called tropical spastic parapare- 
sis (TSP) or HTLV-1-associated myelopathy (HAM) 
[1-4]. Both diseases occur in southwestern Japan and 
the Caribbean basin. Recent studies suggest that 
HTLV-1 infection may also be prevalent in parts of 
Africa. The HTLV-1 antibody prevalence has ranged 
from O to 9% in studies of African blood donors 
and has been as high as 30% in several risk groups 
in tropical Africa [5-141. However, most of the pre- 
liminary investigations in Africa included heterage- 
neous populations, and laboratory studies were done 
A large cross-sectional serologic SUNW for human T cell leukemia virus type 1 (HTLV-1) 
antibody was conducted in 3,177 Ivory Coast residents to evaluate the prevalence of HTLV-1 
and to determine possible risk factors and correlates of HTLV-1 infection. Of the 3,177 
serum samples, 110 (3.5%) were positive for antibody to HTLV-1 by indirect immunoflu- 
orescence assay and Western blot. The prevalence of HTLV-1 antibody in the general adult 
population was 1.8% and increased significantly with age. No difference between males 
(1.5%) and females (2%) was found. The highest prevalences were observed in female 
prostitutes (7.4010). patients with neurologic syndromes (5.8Vo), and lepers (13.7%). The 
high prevalence of HTLV-l infection in prostitutes suggests that heterosexual contact is 
involved in the transmission of HTLV-1 and that prostitutes could play an important role 
in the spread of the virus in Africa. The high prevalence of HTLV-1 in patients with neu- 
rologic syndromes confirms the association between HTLV-1 and some type of neuropa- 
thies, as has been observed in the West Indies and Japan. The high prevalence observed 
in lepers deserves further investigation to find the cause of the association. 'henty-five 
individuals, including prostitutes, were coinfected with HTLV-1 and human immunodefi- 
ciency virus (HIV). Prospective studies are necessary to evaluate the exact role of HTLV-1 
alone or in combination with HIV in inducing specific diseases. 
on stored blood samples. Positive reactions by screen- 
ing procedures were not followed by confirmatory 
assays in most of these studies, which renders the 
conclusions of limited value. We conducted a sero- 
epidemiologic study of HTLV-1 infection in a coun- 
try of West Africa, Ivory Coast, using only recently 
collected serum samples and obtaining a confirma- 
tory assay for every sample that scored positive or 
equivocal in the screening assay. 
Subjects and Methods 
Subjects 
We recruited 3,177 study participants between 
January 1986 and July 1987. Three different popu- 
lations were included: groups representative of the 
general population, groups characterized by sexual 
promiscuity, and patients with specific clinical dis- 
eases or syndromes (table 1). 
The adult groups representative of the general 
population that we enrolled were 513 pregnant wo- 
men (456 from Abidjan, 35 from area €3, and 22 from 
area C; figure I), 155 students (125 men, 30 women) 
from Abidjan consulting at the University medical 
service for a regular check-up, 99 healthy adults (37 
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Table 1. Prevalences for antibodies to HTLV-I and HIV in studied population groups. 
No. (070) positive for antibody to 
Gender 
Subgroup Mean ratio. No. HIV-1 HTLV- 1 
Groups arca . age. y M:F tested HIV-1 HIV-2 and HIV-2 HTLV-1 and HIV 
Neonates Abidjan O ND 188 3 (1.6) 4 (2.1) O 3 (1.6) 1 (0.5) 
Groups representative of the general population 
Children Arcas A and C 9 1.2 176 1 (0.6) O O 2 (1.1) o 
Pregnant women Areas A C  25 F 513 11 (2.1) 5 (0.9) O 10 (1.9) 1 (0.2) 
Students Abidjan 23 4.2 155 2 (1.3) 1 (0.6) 1 (0.6) 1 (0.6) O 
Adult populations Six groups 32 0.9 312 7 (2.2) 4 (1.3) 1 (0.3) 7 (2.2) O 
Hotel staff Arca A -33 M 311 27 (8.7) 5 (1.6) 2 (0.6) 5 (1.6) 1 (0.3) 
Prostitutes Areas A and B 26 F 390 119 (30.5) 99 (25.4) 69 (17.7) 29 (7.4) 15 (3.8) 
Prisoners Abidjan, arca A 31 6.7 270 16 (5.9) 33 (12.2) 1 (0.3) 9 (3.3) 4 (1.5) 
Psychiatric Abidjan 32 2.7 % 5 (5.2) 1 (1.0) O 5 (5.2) O 
Neurologic Abidjan ND 2.9 156 11 (7.0) 7 (4.5) 4 (2.6) 9 (5.8) 3 (1.9) 
Diabetes Areas A and B 50 2.5 163 7 (4.3) 2 (1.2) O 3 (1.8) O 
Sickle cell disease Abidjan 17 0.9 52 5 (9.6) 5 (9.6) 3 (5.8) 2 (3.8) O 
Tuberculosis Abidjan 36 3.1 41 4 (9.7) 2 (4.8) O 1 (2.4) 1 (2.4) 
AIDS-like disease Abidjan 38 3.0 195 63 (32.3) 50 (25.6) 26 (13.3) 8 (4.1) 1 (0.5) 
Leprosy Area A 45 1.1 109 o 2 (1.8) O 15 (13.7) O 
Total 3,177 281 (8.8) 223 (7) 107 (3.4) 110 (3.5) 27 (0.8) 
NOTE. HTLV-1 = human T cell leukemia virus type 1, HIV = human immunodeficiency virus, ND = not done. STD = 
scxudy transmitted disease, F = female. M = male. Individuals with combined HIV-1 and -2 infection are included in the numbers 
for HJV-1 antibody and HIV-2 antibody and in those with combined HTLV-1 and HIV infection. 
Groups characterized by sexual promiscuity 
STD clinic patients Abidjan 21 9.0 50 o 3 (6.0) O 1 (2) 0 
Patient groups 
Figure 1. Location of Ivory Coast and study areas: Arca 
A, southeast, near Ghana. Area J3, north. Area C, north- 
west, near Guinea. ’ 
men, 62 women) recruited from areas A and C for 
toxoplasma serology, 144 adults (60 men, 84 women) 
on the staff of the Abidjan prison, 41 adults (26 men, 
15 women) on the medical staff of the Abidjan hospi- 
tais, and 28 men on the staff of the zoos of Abidjan 
and Bouake. W o  groups of children (126 from area 
A and 50 from area C; 95 boys, 81 girls) consulting 
at the scholar medicine service for a regular check- 
up were also included, as well as 188 neonates from 
Abidjan. We also took samples from 311 men on the 
staff of two tourist hotels in area A. 
The groups characterized by sexual promiscuity 
that we enrolled were 390 female prostitutes (105 
from Abidjan, 163 from area A, and 122 from area 
B), 270 prisoners (235 men, 35 women), and 50 pa- 
tients (45 men, 5 women) presenting with a sexualIy 
transmitted disease (STD, mainly syphilis or gonor- 
rhea) at an STD clinic in Abidjan. Among the Abid- 
jan prostitutes, three subgroups were distinguished 
and were numbered 1-3 with increasing socioeco- 
nomic level as determined by the price for sexual in- 
tercourse: Subgroup 1 charged each customer the 
y, 
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equivalent of US$0.50; subgroup 2, US$3; and sub- 
group 3, US$15-$30 1151. We did not obtain infor- 
mation about the mean number of sexual partners 
per subgroup. Among the prisoners, 193 were from 
the prison of Abidjan and 77 were from a prison in 
area A. 
The groups of patients with specific diseases in- 
cluded 52 multitransfused patients with sickle cell 
anemia from Abidjan, 163 adult diabetics (131 from 
Abidjan and 32 from area B), %psychiatric patients 
from Abidjan, 41 patients from area A undergoing 
ambulatory treatment for tuberculosis, 109 patients 
from area A with leprosy, and 156 patients from 
Abidjan with neurologic disease (including differ- 
ent neuromyelopathies as well as TSP). In addition, 
we enrolled 195 inpatients from Abidjan hospitals 
with an AIDS-like iliness, as defined by a severe re- 
spiratory infection associated with tuberculosis (87% 
of cases), weight loss >lo% of body weight (SO%), 
profound asthenia (83010), or persistent diarrhea 
(26%). 
Methods 
Blood samples were centrifuged to separate the se- 
rum. Serum samples were quickly frozen at -20°C 
and stored until used. 
Serologicassays for antibody to HTLVl. For in- 
direct immunofluorescence assay (IFA), HUT 102 
clone B2 cells were propagated in RPMI 1640 
medium supplemented with 20% inactivated fetal 
calf serum and containing 1% of an antibiotic- 
antimicotic mixture (GIBCO/BRL, Grand Island, 
NY). Medium was changed every 3 d, and the cells 
were subcultured at a split ratio (1 :2). 
To prepare IFA smears, the HUT 102 cells were har- 
vested during the exponential growth phase and cen- 
trifuged at 400 g for 10 min. The pelleted cells were 
resuspended in phosphate-buffered saline (PBS) to 
yield a final density of -2 x 106 cells/ml. Aliquots 
(10 pl) of this suspension were loaded in 10-well glass 
slides (Wiener, Saint-Etienne, France) and air dried. 
The dried cells were then fixed in acetone at -20°C 
for 10 min and stored frozen. 
For IFA, 20 pl of a 130 dilution in PBS of test 
serum was incubated with the cells for 45 min at 37°C 
in a humid atmosphere and rinsed twice in PBS. The 
staining was performed by adding 20 p1 of a 11200 
dilution of fluorescein isothiocyanate-conjugated 
goat antibody to human IgG (Fluoline G; Bio- 
Merieux, Marcy l'Etoile, France). After incubation 
at 37°C for 30 min, the slides were rinsed twice with 
PBS and examined with an Olympus (BH2) fluo- 
rescent microscope. Figure 2 shows the typical pat- 
tern observed by IFA. 
Serum with a positive or equivocal result by IFA 
was further analyzed for confirmation by Western 
blotting. We used a previously described procedure 
[2] with minor modifications. Briefly, 200 pl of a 
HUT 102 clone B2 cell lysate (corresponding to lo7 
. I  
Figure' 'i Representative negative (A) 
and positive (B) patterns of immuno- 
fluorescence assay with Hul' 102 fixed 
cells. 
\ 
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cells) or 200 p1 of a virus pellet prepared as described 
[15] from 60 ml of a 24-h supernatant from H a  102 
cells (3 x 106 cells/ml) was mixed with 200 pl of 
twofoldconcentrated sample buffer. These mixtures 
were fractionated by electrophoresis on 10% poly- 
acrylamide slab gel in the presence of sodium dodecyl 
sulfate according to the procedure of Laemmli [16]. 
After electrophoresis, the gels were washed for 30 
min in three changes of transfer buffer (10 &Tris- 
HCl [pH 7.0],2 mMEDTA, 50 mMNaC1). The pro- 
teins in the gels were then passively transferred to 
nitrocellulose by incubating a nitrocellulose-gel 
“sandwich” for 36 h at room temperature. The 
nitrocellulose sheets were incubated at 37°C for 1 h 
with 10% nonfat dry milk in 10 mM sodium phos- 
phate buffer (PH 7.4) containing 150 mM NaCl 
(PBS) and were cut into 0.3-cm strips. After three 
washings in PBS containing 1% f ieen  20 (PBS-T), 
each strip was incubated overnight at room temper- 
ature with 3 ml of a 1300 dilution of test serum in 
PBS supplemented with 5% nonfat dry milk in PBS- 
T. The strips were washed three times with PBS-T. 
Affinity-purified and biotin-labeled sheep anti- 
bodies to human IgG (dilution 1:400 in PBS-’ 
Amersham International P E ,  Amersham, UK) 
were added to the strips, and they were incubated 
at 37°C for 2 h. After the strips were washed three 
more times with PBST, a 1:W dilution of pre- 
formed streptavidin-biotinylated horseradish perox- 
idase complex (Amersham) in PBS-T was added to 
the strips, and they were incubated at room temper- 
ature for 30 min. After three more washings, the 
strips’ peroxidase activity was detected colorimetri- 
cally by the addition of a fresh solution of di- 
aminobenzidine (50 mg in 100 ml of PBS, sup- 
plemented with 0.01% hydrogen peroxide). 
The main HTLV-I antigens detected by positive 
serum samplee..:ncluded the gag-encoded prqteins 
p19, p24, and 1 ’:.-and the env-encoded glycoproteins 
gp61 (for the cr> lysate) and gp46 (for the virus pel- 
let). Samples web considered positive for antibody 
to HTLV-1 if they reacted with at least the envelope 
protein and one of two major gag proteins, p24 and 
p19. Figure 3 shows representative Western blots 
using a virus pellet as antigen. 
. Other mays. Every serum sample was also 
tested for the presence of antibody to human im- 
munodeficiency virus types 1 and 2 (HIV-1, HIV-2) 
by procedures already described [15]. The prevalence 
of antibody to these viruses in Ivory Coast has been 
published [15,17]. All the samples were also tested 
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Figure 3. Representative Western blots with HTLV-1 an- 
tigens. Lanes A-D: positive samples. Lane E negative 
sample. 
for antibody to %ponema pallidum by using a 
hemagglutination assay (SeraTek MHATP; Miles, 
Fujirebio, Tokyo) and antibody to Chlamydia tmcho- 
matis by immunofluorescence assay (C trachoma- 
tis-spot IF, BioMerieux). Serum was considered posi- 
tive for antibody to C trachomatis when it reacted 
at dilutions of 136 for men and 1:64 for women [IS] 
and positive for antibody to T pallìdum when the 
antibody titer was 81:SO [15]. 
Statistical tests. The x2 test was used for com- 
parison of proportions between groups. Logistic 
regression analysis was used to determine the possi- 
ble correlation between HTLV-1 and STD agents. 
Results 
Of the 3,177 samples,. 110 (3.5%) were positive for 
antibody to HTLV-1 (table 1). Among the 1,291 in- 
dividuals representing the general adult population, 
23 (1.8%) wes positive for antibody to HTLV-1. 
There was no significant difference between preva- 
, HTLW seroprevalence in Ivory coari 361 1 '  
Table 2. Prevalences of HTLV-I and sexually transmitted agents in two groups of women. 
No. (Vo) positive for antibody to 
No. Mean Treponema Chlamydia 
Groups tested age. Y paUídum trachomatir HIV HTLV-I 
Pregnant women 
Abidjan 
Area B 
Area C 
Total 
Prostitutes 
Abidjan 
Subgroup 1 
Subgroup 2 
Subgroup 3 
Area A 
Area B 
Total 
456 
35 
22 
513 
42 
45 
18 
163 
I22 
390 
25 
25 
26 
25 
27 
28 
23 
27 
26 
26 
35 (7.7) 
2 (5.7) 
2 (9.0) 
39 (7.6) 
31 (73.8) 
11 (24.4) 
84 (5 1.5) 
66 (54.0) 
192 (49.2) 
O 
97 (21.3) 
7 (20.0) 
2 (9.0) 
106 (20.7) 
33 (78.6) 
22 (49.0) 
6 (33.0) 
99 (60.7) 
93 (76.2) 
253 (64.9) 
15 (3.3) 9 (1.9) 
O 1 ,(4.5) 
16 (3.1) 10 (1.9) 
1 (2.8) O 
25 (59.5) 7 (16.7) 
Il (24.4) 4 (8.9) 
2 (11.1) O 
31 (25.4) 7 (5.7) 
80 (49.0) I l  (6.7) 
149 (38.2) 29 (7.4) 
lences observed within the different groups. The rate 
of seropositivity was similar in pregnant women from 
Abidjan (1.59'0) or from areas B and C (1.7%). In 
this adult population, the prevalence of antibody to 
HTLV-1 was similar in males (1.5%) and females 
(2%). Five (1.4%) of 364 children were positive for 
antibody to HTLV-1. 
Nine (3.3%) of 270 prisoners and one (2'3'0) of 50 
patients with STD were positive for antibody to 
HTLV-I. These prevalences were not statistically 
different from that observed in the general adult 
population. Antibody to HTLV-I was detected in 29 
(7.4%) of 390 prostitutes. This prevalence was sig- 
nificantly higher than that of the general adult popu- 
lation (P < .OOl). Among the prostitutes living in 
Abidjan, the rate of HTLV-1 seropositivity was in- 
versely proportional to socioeconomic level (table 
2). The prevalence was 16.7% in subgroup 1,8.9% 
in subgroup 2, and O in subgroup 3. However,?hese 
differences were not statistically signify 'ant (x' test). 
In prostitutes and pregnant womt i, .-!here was a 
correlation between the prevalence U; antibody to 
HTLV-1 and the prevalence of antibody to the sexu- 
ally transmitted agents HIV-1, HIV-2, X pallidum, 
and C tmchomatis (table 3). 
The rate of lTIXV-1 seropositivity was significantly 
higher in patients with certain diseases compared 
with the general adult population (table 1). Among 
these patients, the highest HTLV-1 seroprevalences 
were observed with neurologic disease (5.8%, P < 
-01) and leprosy (13.7%, P < -001). 
The prevalence of antibody to HTLV-1 increased 
. 
with age.(figure 4). The HTLV-I seroprevalence was 
1.5% at age <20 y, 3.5% at 20-40 y (P < .05), and 
8.8% at >40 y (P < .001). There was no difference 
in HTLV-I seroprevalence according to gender. 
Twenty-seven individuals, mainly prostitutes, pri- 
soners, and neurologic patients (respectively, 15, 4, 
and 3 ind'ividuals) were coinfected with HTLV-1 and 
HIV-I or -2 (table 1). 
Discussion 
This study was performed using only recently col- 
lected serum samples in Ivory Coast, so the results 
are representative of the present HTLV-1 infection 
rate in this country. Every sample that was positive 
Table 3. Correlation between prevalences of antibod- 
ies to HTLV-1 and other sexually transmitted diseasc 
(STD) agents. - 
Treponema Chlamydia 
HIV pallidum Irachomatis 
HTLV-I 0.8172 0.8854 0.9075 
HIV 0.9193 0.7301 
P <  .o2 P <  .o1 P < .o1 
P < .o1 P < .o5 
P < .o1 
T. pallidum 0.9010 
NOTE. Numbax indiate correlation coefficient according 
to logistic regression analysis. This value is done for SIP agents 
studied in pregnant women and prostitutes. HTLV-1 = human 
T cell leukemia virus type 1, HIV = human immunodcfiaency 
virus. 
9 '  
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Figure 4. HTLV-I seroprevalence ac- 
cording to age for women (8). men 
(El), and both (U). 
I..,. < PO 20-29 30-39 40-49 >eo 
or equivocal by immunofluorescence was systemat- 
ically tested by Western blot using a crude HUT 102 
cell lysate or a virus pellet. The criteria for positiv- 
ity for antibody to HTLV-1 by Western blot included 
a positive reaction with the envelope glycoproteins 
gp61 or gp46 [19] and at least one of the major gag 
proteins p24 and p19. More recent studies indicate 
that the samples we considered positive for antibody 
to HTLV-1 were also confirmed by a newly developed 
enzyme-linked immunosorbent assay and radio- 
immunoprecipitation assay [20]. 
This study demonstrated a relatively high preva- 
lence of antibody to HTLV-1 in Ivory Coast. Of the 
adults representing the general population, 1.8% 
were positive for antibody to HTLV-I. This rate is 
similar to the seroprevalence observed in compara- 
ble African populations when serologic criteria were 
used in confirmatory assays. For example, in 
1983-1984 Hunsmann et al. [lo] found HTLV-1 an- 
tibody rates of 3.9'3'0, 1.7%, l.6Pl0, 2.6%, 1.2% and 
3.2% in Gabon, Kenya, Liberia, Nigeria, Senegal, 
and Zaire, respectively. Similarly Fleming et al. [9] 
found a prevalence of antibody to HTLV.1 of 2.0qo 
in Nigerian blood donors in 1986. 
As was previously observed in endemic : Izas such 
as Japan [21] and the West Indies [4], the HTLV-1 
seropositivity rate increases with age in Ivory Coast. 
Concerning seroprevalence according to gender, the 
difference was not significant in the general adult 
population (1.5% for males, 2% for females). Simi- 
lar results were found by Biggar et al. [5] in Ghana: 
4.1% for males, 3.4% for females. The African 
results differ from those observed in Japan, where 
the prevalence is higher in females (18.5%) than in 
males (12.2%) [21]. 
Prostitutes had a higher prevalence of antibody 
to HTLV-1 than did the general adult population. 
This higher seròprevalence in prostitutes and the 
correlation between exposure to HTLV-1 and ex- 
posure to sexually transmitted agents (T pallidum, 
C trachomatis, HIV-1, and HIV-2) suggests that het- 
erosexual contact is involved in the transmission of 
HTLV-1 in Africa. Prostitutes may then be an im- 
portant factor in spread of HTLV-1 in Africa as they 
are for spread of HIV [15]. 
Severai groups of patients had significantly higher 
prevalences of antibody to HTLV-1 than the adult 
population. However, it remains to be demonstrated 
whether this higher HTLV-1 prevalence is pathogen- 
ically linked to the diseases studied. Since it has been 
shown that HTLV-1 is associated with neurologic 
disease (TSP or HAM) in the West Indies and Ja- 
pan, it may be suggested that the high HTLV-1 
seroprevalence observed in Ivory Coast patients with 
neuromyelopathy is a causal association. However, 
another study conducted on tropical neuromyelopa- 
thies from Abidjan [22] showed that HTLV-1 seemed 
to play a limited pathogenic role (1 positive case out 
of 29), suggesting that development of neuromye- 
lopathies in Africa is probably fostered by nutritional 
and toxicologic problems. 
The highest prevalence of antibody to HTLV-1 was 
observed in a group of lepers living in a single vil- 
lage. Since these clustered patients received frequent 
therapeutic injections, it may be that this high pre- 
valence was due to nosocomial transmission However, 
other groups of patients characterized by frequent 
injections (tuberculosis patients) or transfusions 
(sickle cell disease patients) had much lower rates 
of HTLV-1 infection. In addition, the leprosy patients 
had a low rate of HIV infection, in contrast to the 
tuberculosis and sickle cell disease groups. Prelimi- 
HTLV-I Seroprrvalence in Ivory Coas1 
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nary data from other groups of lepers in Ivory Coast 
and other African countries, have confirmed this ob- 
servation of high HTLV-1 prevalence (unpublished 
data). 
Of 3,177 participants, 27 (0.8%) showed serologic 
evidence for coinfection with HIV-1 or -2 and HTLV- 
1. Rare cases of dual infection have been previously 
reported in African patients 123,241. It has been re- 
cently shown that HIV-1 production from the periph- 
eral blood leukocytes is increased after in vitro 
HTLV-1-induced mitogenic stimulation [25]. Patients 
coinfected with both viruses might thus produce 
more HIV-1 than those not infected with HTLV-I. 
Bartholomew et al. [26], in Trinidad, described a 
higher prevalence of AIDS in homosexual men coin- 
fected by HTLV-1 and HIV than in those infected 
by HIV alone. They suggested that the first virus ac- 
quired (probably HTLV-1) enhanced the pathogenic- 
ity of the second (HIV). 
Prospective studies are now necessary in Ivory 
Coast to clarify the exact role of HTLV-1 in induc- 
ing specific diseases (adult T cell leukemia, non- 
Hodgkin lymphomas, neuromyelopathies) and the 
clinical and biologic events occurring in those coin- 
fected with HIV and HTLV-I. 
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